Faron Pharmaceuticals Oy (AIM:FARN)
London · Delayed Price · Currency is GBP · Price in GBX 35.06
-1.44 (-3.95%)
Oct 15, 2026, 12:11 PM GMT
Faron Pharmaceuticals Oy Market Cap
Faron Pharmaceuticals Oy has a market cap or net worth of 72.41 million as of October 14, 2026. It is the 25,315th most valuable company in the world and the 560th biggest in the United Kingdom. Its market cap has decreased by 64.04% in one year.
Market Cap
72.41M
Enterprise Value
60.30M
Revenue
n/a
Global Rank
Country Rank
#560 United Kingdom
PE Ratio
n/a
ChartMarket Cap Chart
Since November 17, 2015, Faron Pharmaceuticals Oy's market cap has increased from 53.46M to 72.41M, an increase of 35.45%. That is a compound annual growth rate of 2.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 72.41M | -64.84% |
| Dec 31, 2025 | 205.96M | -3.97% |
| Dec 31, 2024 | 214.48M | 2.23% |
| Dec 29, 2023 | 209.80M | 16.93% |
| Dec 30, 2022 | 179.42M | 26.00% |
| Dec 31, 2021 | 142.40M | 16.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Avacta Group | 317.38M |
| PureTech Health | 278.03M |
| Scancell Holdings | 113.04M |
| Bioventix | 94.62M |
| 4basebio | 87.40M |
| Poolbeg Pharma | 51.91M |
| Ondine Biomedical | 50.66M |
| Hemogenyx Pharmaceuticals | 50.39M |